Wednesday 7 August 2019

FDA: Pricey Drug Approved on Manipulated Data

fda

The FDA approved the gene therapy Zolgensma to treat children with a severe form of spinal muscular atrophy. The drug costs $2.125 million for a one-time treatment, CBS News reported.



from WebMD Health https://ift.tt/2ZFHnVR

0 comments:

Post a Comment